Financial News
All News about Veracyte Inc
![](https://mms.businesswire.com/media/20230417005276/en/1764772/5/Multi-color_Logo_RGB_Jan_2023.jpg)
![](https://mms.businesswire.com/media/20230413005769/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
From Veracyte, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230412005237/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](/next-assets/images/schema-image-default.png)
A Preview Of Veracyte's Earnings
February 21, 2023
Via Benzinga
Expert Ratings for Veracyte
January 05, 2023
Via Benzinga
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
Via Talk Markets
![](https://mms.businesswire.com/media/20230315005836/en/1739845/5/Multi-color_Logo_RGB_Jan_2023.jpg)
![](https://investorplace.com/wp-content/uploads/2022/04/pte_biotech_1600-1024x576.png)
![](https://mms.businesswire.com/media/20230311005054/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_3608.jpeg?width=1200&height=800&fit=crop)
Veracyte Earnings Perspective: Return On Capital Employed
November 16, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/723764/a-doctor-examines-a-patient.jpg)
![](https://mms.businesswire.com/media/20230227005850/en/1724509/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte to Participate in Upcoming Investor Conferences
February 27, 2023
From Veracyte, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20230222005326/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
Veracyte Announces Fourth Quarter and Full-Year 2022 Financial Results
February 22, 2023
From Veracyte, Inc.
Via Business Wire
![](https://i0.wp.com/raygent.com/wp-content/uploads/2023/02/image-6.png)
![](https://mms.businesswire.com/media/20230214005701/en/1713354/5/Multi-color_Logo_RGB_Jan_2023.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_118.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230213005525/en/1712057/5/Multi-color_Logo_RGB_Jan_2023.jpg)
![](https://mms.businesswire.com/media/20230206005607/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://i0.wp.com/raygent.com/wp-content/uploads/2023/02/image.png)
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
February 05, 2023
Via Talk Markets
![](https://mms.businesswire.com/media/20230201005995/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://mms.businesswire.com/media/20230201005374/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://g.foolcdn.com/editorial/images/717236/scientist-altering-dna-genome-project.jpg)
![](https://ml.globenewswire.com/media/1008ba13-c3b0-4464-a6f3-60b9470aa25e/small/exagen-logo-440x386-1-jpg.jpg)
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
January 23, 2023
From Exagen Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/01/18/general.png?width=1200&height=800&fit=crop)
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
January 18, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/716736/a-patient-at-an-appointment-with-their-doctor.jpg)
![](https://mms.businesswire.com/media/20221214006009/en/791654/5/Veracyte_RGB_LRG_H_registered.jpg)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.